{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-000695","form_type":"8-K","ticker":"MBRX","cik":"0001659617","company_name":"Moleculin Biotech, Inc.","filed_at":"2026-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.791750+00:00","generated_at":"2026-05-16T11:22:34.657842+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Moleculin Biotech regains Nasdaq compliance, avoiding delisting","bullets":["Nasdaq staff notified Panel on Jan 6, 2026 that Moleculin regained compliance with Listing Rule 5550(b)(1) (min $2.5M equity).","Company received delist determination on Nov 20, 2025 and had appealed; hearing now cancelled.","Company is in compliance with all applicable Nasdaq continued listing standards as of Jan 6, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-000695","json":"https://secwatch.observer/filing/0001437749-26-000695.json","markdown":"https://secwatch.observer/filing/0001437749-26-000695.md","text":"https://secwatch.observer/filing/0001437749-26-000695.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926000695/0001437749-26-000695-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926000695/mbrx20260106_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:22:34.657842+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}